Skip to main content
Top
Published in:

17-07-2024 | AL Amyloidosis | Letter to the Editor

Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine

Authors: Yosuke Matsumoto, Tetsuya Masuda, Mihoko Yoshida, Kazuho Shimura, Hiroto Kaneko, Masafumi Taniwaki

Published in: International Journal of Hematology | Issue 3/2024

Login to get access

Excerpt

We previously reported a case of follicular lymphoma (FL) with plasmacytic differentiation (PCD) (FL-PCD) in the ileum as a first case of amyloid light chain (AL) amyloidosis associated with FL [1]. Recently, Tajima et al. reported a case of FL-PCD associated with AL amyloidosis in the jejunum [2]. Both cases had the following pathophysiological features in common:
1.
The histological grade of FL was grade 1.
 
2.
FL was accompanied by PCD. Cytogenetic studies showed that the plasma cells originated not from reactive lymphocytes but rather from neoplastic FL cells. These plasma cells distributed in interfollicular lesions. In both cases, both FL cells and infiltrating plasma cells were immunohistochemically positive for BCL2.
 
3.
Localized lambda AL amyloid was deposited adjacent to neoplastic lymphoid follicles.
 
4.
Both patients were female.
 
Literature
1.
go back to reference Matsumoto Y, Masuda T, Nishimura A, Horie H, Harada K, Yoshida M, et al. A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation. Int J Hematol. 2020;111:317–23.CrossRefPubMed Matsumoto Y, Masuda T, Nishimura A, Horie H, Harada K, Yoshida M, et al. A case of AL amyloidosis associated with follicular lymphoma with plasmacytic differentiation. Int J Hematol. 2020;111:317–23.CrossRefPubMed
2.
go back to reference Tajima K, Nomura T, Terada T, Okuyama S, Kumagai H, Maeda K, et al. Solitary follicular lymphoma with plasmacytic differentiation associated with localized AL amyloidosis in the jejunum. Ann Hematol. 2023;102:1625–7.CrossRefPubMed Tajima K, Nomura T, Terada T, Okuyama S, Kumagai H, Maeda K, et al. Solitary follicular lymphoma with plasmacytic differentiation associated with localized AL amyloidosis in the jejunum. Ann Hematol. 2023;102:1625–7.CrossRefPubMed
3.
go back to reference Gibson SE, Liu YC, Yatsenko SA, Barasch NJ, Swerdlow SH. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. Mod Pathol. 2022;35:60–8.CrossRefPubMed Gibson SE, Liu YC, Yatsenko SA, Barasch NJ, Swerdlow SH. Histopathologic, immunophenotypic, and mutational landscape of follicular lymphomas with plasmacytic differentiation. Mod Pathol. 2022;35:60–8.CrossRefPubMed
4.
go back to reference Ohnishi N, Takata K, Miyata-Takata T, Sato Y, Tari A, Gion Y, et al. CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine. Cancer Sci. 2016;107:1687–95.CrossRefPubMedPubMedCentral Ohnishi N, Takata K, Miyata-Takata T, Sato Y, Tari A, Gion Y, et al. CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine. Cancer Sci. 2016;107:1687–95.CrossRefPubMedPubMedCentral
Metadata
Title
Characteristic and recurrent pathophysiological features of non-duodenal follicular lymphoma of the small intestine
Authors
Yosuke Matsumoto
Tetsuya Masuda
Mihoko Yoshida
Kazuho Shimura
Hiroto Kaneko
Masafumi Taniwaki
Publication date
17-07-2024
Publisher
Springer Nature Singapore
Published in
International Journal of Hematology / Issue 3/2024
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-024-03820-1

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more